Showing results (11-20 of 344) with videos related to
Sort By:
Pageof 35
Antiviral Therapy|September 7, 2013
Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritisStella De Nicola, Alessio Aghemo, Maria Rosaria Campise, et al.Antiviral Therapy|February 22, 2007
Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infectionAlessio Aghemo, Maria Grazia Rumi, Roberta Soffredini, et al.Journal of Hepatology|March 27, 2013
The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological responseRoberta D'Ambrosio, Alessio Aghemo, Mirella Fraquelli, et al.Hepatology (Baltimore, Md.)|January 25, 2012
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosisRoberta D'Ambrosio, Alessio Aghemo, Maria Grazia Rumi, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2017
Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosisArmando Tripodi, Roberta D'Ambrosio, Lidia Padovan, et al.Hepatitis Monthly|February 7, 2012
Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patientsAlessio Aghemo, Maria Grazia Rumi, Sara Monico, et al.Plos One|April 25, 2014
Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving TelaprevirAlessio Aghemo, Eleonora Grassi, Maria Grazia Rumi, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV InfectionElisabetta Degasperi, Roberta D'Ambrosio, Massimo Iavarone, et al.Journal of Hepatology|July 16, 2011
Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosisGian Maria Prati, Alessio Aghemo, Maria Grazia Rumi, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2016
Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus InfectionAlessio Aghemo, Elisabetta Degasperi, Stella De Nicola, et al.Pageof 35